Hmdb loader
Record Information
Version5.0
StatusDetected but not Quantified
Creation Date2021-09-11 17:49:33 UTC
Update Date2021-09-26 23:13:18 UTC
HMDB IDHMDB0257137
Secondary Accession NumbersNone
Metabolite Identification
Common NameRegorafenib
DescriptionRegorafenib, also known as bay 73-4506 or stivarga, belongs to the class of organic compounds known as diarylethers. These are organic compounds containing the dialkyl ether functional group, with the formula ROR', where R and R' are aryl groups. Based on a literature review a significant number of articles have been published on Regorafenib. This compound has been identified in human blood as reported by (PMID: 31557052 ). Regorafenib is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically Regorafenib is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources.
Structure
Thumb
Synonyms
ValueSource
BAY 73-4506ChEBI
RegorafenibumChEBI
StivargaKegg
4-(4-(((4-chloro-3-(Trifluoromethyl)phenyl)carbamoyl)amino)-3-fluorophenoxy)-N-methylpyridine-2-carboxamideMeSH
Chemical FormulaC21H15ClF4N4O3
Average Molecular Weight482.815
Monoisotopic Molecular Weight482.076880893
IUPAC Name4-[4-({[4-chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)-3-fluorophenoxy]-N-methylpyridine-2-carboxamide
Traditional Nameregorafenib
CAS Registry NumberNot Available
SMILES
CNC(=O)C1=CC(OC2=CC(F)=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N1
InChI Identifier
InChI=1S/C21H15ClF4N4O3/c1-27-19(31)18-10-13(6-7-28-18)33-12-3-5-17(16(23)9-12)30-20(32)29-11-2-4-15(22)14(8-11)21(24,25)26/h2-10H,1H3,(H,27,31)(H2,29,30,32)
InChI KeyFNHKPVJBJVTLMP-UHFFFAOYSA-N
Chemical Taxonomy
Description Belongs to the class of organic compounds known as diarylethers. These are organic compounds containing the dialkyl ether functional group, with the formula ROR', where R and R' are aryl groups.
KingdomOrganic compounds
Super ClassOrganic oxygen compounds
ClassOrganooxygen compounds
Sub ClassEthers
Direct ParentDiarylethers
Alternative Parents
Substituents
  • Diaryl ether
  • N-phenylurea
  • Trifluoromethylbenzene
  • Pyridinecarboxamide
  • Pyridine carboxylic acid or derivatives
  • 2-heteroaryl carboxamide
  • Phenoxy compound
  • Phenol ether
  • Halobenzene
  • Fluorobenzene
  • Chlorobenzene
  • Aryl chloride
  • Aryl fluoride
  • Aryl halide
  • Monocyclic benzene moiety
  • Benzenoid
  • Pyridine
  • Heteroaromatic compound
  • Carboxamide group
  • Carbonic acid derivative
  • Secondary carboxylic acid amide
  • Urea
  • Azacycle
  • Carboxylic acid derivative
  • Organoheterocyclic compound
  • Organonitrogen compound
  • Alkyl halide
  • Alkyl fluoride
  • Carbonyl group
  • Hydrocarbon derivative
  • Organic oxide
  • Organopnictogen compound
  • Organic nitrogen compound
  • Organofluoride
  • Organochloride
  • Organohalogen compound
  • Aromatic heteromonocyclic compound
Molecular FrameworkAromatic heteromonocyclic compounds
External Descriptors
Ontology
Physiological effectNot Available
Disposition
ProcessNot Available
RoleNot Available
Physical Properties
StateNot Available
Experimental Molecular Properties
PropertyValueReference
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water SolubilityNot AvailableNot Available
LogPNot AvailableNot Available
Experimental Chromatographic PropertiesNot Available
Predicted Molecular Properties
PropertyValueSource
logP4.53ALOGPS
logP4.49ChemAxon
logS-5.7ALOGPS
pKa (Strongest Acidic)10.52ChemAxon
pKa (Strongest Basic)2.02ChemAxon
Physiological Charge0ChemAxon
Hydrogen Acceptor Count3ChemAxon
Hydrogen Donor Count3ChemAxon
Polar Surface Area92.35 ŲChemAxon
Rotatable Bond Count6ChemAxon
Refractivity114.73 m³·mol⁻¹ChemAxon
Polarizability41.23 ųChemAxon
Number of Rings3ChemAxon
BioavailabilityYesChemAxon
Rule of FiveYesChemAxon
Ghose FilterNoChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleYesChemAxon
Predicted Chromatographic Properties

Predicted Collision Cross Sections

PredictorAdduct TypeCCS Value (Å2)Reference
DeepCCS[M+H]+202.34130932474
DeepCCS[M-H]-199.94530932474
DeepCCS[M-2H]-232.82930932474
DeepCCS[M+Na]+208.32230932474
AllCCS[M+H]+204.432859911
AllCCS[M+H-H2O]+202.332859911
AllCCS[M+NH4]+206.332859911
AllCCS[M+Na]+206.932859911
AllCCS[M-H]-193.032859911
AllCCS[M+Na-2H]-192.432859911
AllCCS[M+HCOO]-192.032859911

Predicted Kovats Retention Indices

Underivatized

MetaboliteSMILESKovats RI ValueColumn TypeReference
RegorafenibCNC(=O)C1=CC(OC2=CC(F)=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N14629.2Standard polar33892256
RegorafenibCNC(=O)C1=CC(OC2=CC(F)=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N13272.0Standard non polar33892256
RegorafenibCNC(=O)C1=CC(OC2=CC(F)=C(NC(=O)NC3=CC=C(Cl)C(=C3)C(F)(F)F)C=C2)=CC=N13808.9Semi standard non polar33892256

Derivatized

Derivative Name / StructureSMILESKovats RI ValueColumn TypeReference
Regorafenib,1TMS,isomer #1CN(C(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(C(F)(F)F)=C3)C(F)=C2)=CC=N1)[Si](C)(C)C3589.9Semi standard non polar33892256
Regorafenib,1TMS,isomer #1CN(C(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(C(F)(F)F)=C3)C(F)=C2)=CC=N1)[Si](C)(C)C3047.6Standard non polar33892256
Regorafenib,1TMS,isomer #1CN(C(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(C(F)(F)F)=C3)C(F)=C2)=CC=N1)[Si](C)(C)C4205.7Standard polar33892256
Regorafenib,1TMS,isomer #2CNC(=O)C1=CC(OC2=CC=C(N(C(=O)NC3=CC=C(Cl)C(C(F)(F)F)=C3)[Si](C)(C)C)C(F)=C2)=CC=N13370.0Semi standard non polar33892256
Regorafenib,1TMS,isomer #2CNC(=O)C1=CC(OC2=CC=C(N(C(=O)NC3=CC=C(Cl)C(C(F)(F)F)=C3)[Si](C)(C)C)C(F)=C2)=CC=N12985.8Standard non polar33892256
Regorafenib,1TMS,isomer #2CNC(=O)C1=CC(OC2=CC=C(N(C(=O)NC3=CC=C(Cl)C(C(F)(F)F)=C3)[Si](C)(C)C)C(F)=C2)=CC=N14390.0Standard polar33892256
Regorafenib,1TMS,isomer #3CNC(=O)C1=CC(OC2=CC=C(NC(=O)N(C3=CC=C(Cl)C(C(F)(F)F)=C3)[Si](C)(C)C)C(F)=C2)=CC=N13364.7Semi standard non polar33892256
Regorafenib,1TMS,isomer #3CNC(=O)C1=CC(OC2=CC=C(NC(=O)N(C3=CC=C(Cl)C(C(F)(F)F)=C3)[Si](C)(C)C)C(F)=C2)=CC=N12916.8Standard non polar33892256
Regorafenib,1TMS,isomer #3CNC(=O)C1=CC(OC2=CC=C(NC(=O)N(C3=CC=C(Cl)C(C(F)(F)F)=C3)[Si](C)(C)C)C(F)=C2)=CC=N14423.0Standard polar33892256
Regorafenib,2TMS,isomer #1CN(C(=O)C1=CC(OC2=CC=C(N(C(=O)NC3=CC=C(Cl)C(C(F)(F)F)=C3)[Si](C)(C)C)C(F)=C2)=CC=N1)[Si](C)(C)C3396.0Semi standard non polar33892256
Regorafenib,2TMS,isomer #1CN(C(=O)C1=CC(OC2=CC=C(N(C(=O)NC3=CC=C(Cl)C(C(F)(F)F)=C3)[Si](C)(C)C)C(F)=C2)=CC=N1)[Si](C)(C)C2916.7Standard non polar33892256
Regorafenib,2TMS,isomer #1CN(C(=O)C1=CC(OC2=CC=C(N(C(=O)NC3=CC=C(Cl)C(C(F)(F)F)=C3)[Si](C)(C)C)C(F)=C2)=CC=N1)[Si](C)(C)C3838.5Standard polar33892256
Regorafenib,2TMS,isomer #2CN(C(=O)C1=CC(OC2=CC=C(NC(=O)N(C3=CC=C(Cl)C(C(F)(F)F)=C3)[Si](C)(C)C)C(F)=C2)=CC=N1)[Si](C)(C)C3388.4Semi standard non polar33892256
Regorafenib,2TMS,isomer #2CN(C(=O)C1=CC(OC2=CC=C(NC(=O)N(C3=CC=C(Cl)C(C(F)(F)F)=C3)[Si](C)(C)C)C(F)=C2)=CC=N1)[Si](C)(C)C2820.7Standard non polar33892256
Regorafenib,2TMS,isomer #2CN(C(=O)C1=CC(OC2=CC=C(NC(=O)N(C3=CC=C(Cl)C(C(F)(F)F)=C3)[Si](C)(C)C)C(F)=C2)=CC=N1)[Si](C)(C)C3899.5Standard polar33892256
Regorafenib,2TMS,isomer #3CNC(=O)C1=CC(OC2=CC=C(N(C(=O)N(C3=CC=C(Cl)C(C(F)(F)F)=C3)[Si](C)(C)C)[Si](C)(C)C)C(F)=C2)=CC=N13244.5Semi standard non polar33892256
Regorafenib,2TMS,isomer #3CNC(=O)C1=CC(OC2=CC=C(N(C(=O)N(C3=CC=C(Cl)C(C(F)(F)F)=C3)[Si](C)(C)C)[Si](C)(C)C)C(F)=C2)=CC=N12878.7Standard non polar33892256
Regorafenib,2TMS,isomer #3CNC(=O)C1=CC(OC2=CC=C(N(C(=O)N(C3=CC=C(Cl)C(C(F)(F)F)=C3)[Si](C)(C)C)[Si](C)(C)C)C(F)=C2)=CC=N14031.3Standard polar33892256
Regorafenib,3TMS,isomer #1CN(C(=O)C1=CC(OC2=CC=C(N(C(=O)N(C3=CC=C(Cl)C(C(F)(F)F)=C3)[Si](C)(C)C)[Si](C)(C)C)C(F)=C2)=CC=N1)[Si](C)(C)C3271.9Semi standard non polar33892256
Regorafenib,3TMS,isomer #1CN(C(=O)C1=CC(OC2=CC=C(N(C(=O)N(C3=CC=C(Cl)C(C(F)(F)F)=C3)[Si](C)(C)C)[Si](C)(C)C)C(F)=C2)=CC=N1)[Si](C)(C)C2854.2Standard non polar33892256
Regorafenib,3TMS,isomer #1CN(C(=O)C1=CC(OC2=CC=C(N(C(=O)N(C3=CC=C(Cl)C(C(F)(F)F)=C3)[Si](C)(C)C)[Si](C)(C)C)C(F)=C2)=CC=N1)[Si](C)(C)C3596.9Standard polar33892256
Regorafenib,1TBDMS,isomer #1CN(C(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(C(F)(F)F)=C3)C(F)=C2)=CC=N1)[Si](C)(C)C(C)(C)C3815.0Semi standard non polar33892256
Regorafenib,1TBDMS,isomer #1CN(C(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(C(F)(F)F)=C3)C(F)=C2)=CC=N1)[Si](C)(C)C(C)(C)C3173.5Standard non polar33892256
Regorafenib,1TBDMS,isomer #1CN(C(=O)C1=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(C(F)(F)F)=C3)C(F)=C2)=CC=N1)[Si](C)(C)C(C)(C)C4256.3Standard polar33892256
Regorafenib,1TBDMS,isomer #2CNC(=O)C1=CC(OC2=CC=C(N(C(=O)NC3=CC=C(Cl)C(C(F)(F)F)=C3)[Si](C)(C)C(C)(C)C)C(F)=C2)=CC=N13580.8Semi standard non polar33892256
Regorafenib,1TBDMS,isomer #2CNC(=O)C1=CC(OC2=CC=C(N(C(=O)NC3=CC=C(Cl)C(C(F)(F)F)=C3)[Si](C)(C)C(C)(C)C)C(F)=C2)=CC=N13145.7Standard non polar33892256
Regorafenib,1TBDMS,isomer #2CNC(=O)C1=CC(OC2=CC=C(N(C(=O)NC3=CC=C(Cl)C(C(F)(F)F)=C3)[Si](C)(C)C(C)(C)C)C(F)=C2)=CC=N14370.3Standard polar33892256
Regorafenib,1TBDMS,isomer #3CNC(=O)C1=CC(OC2=CC=C(NC(=O)N(C3=CC=C(Cl)C(C(F)(F)F)=C3)[Si](C)(C)C(C)(C)C)C(F)=C2)=CC=N13577.2Semi standard non polar33892256
Regorafenib,1TBDMS,isomer #3CNC(=O)C1=CC(OC2=CC=C(NC(=O)N(C3=CC=C(Cl)C(C(F)(F)F)=C3)[Si](C)(C)C(C)(C)C)C(F)=C2)=CC=N13044.7Standard non polar33892256
Regorafenib,1TBDMS,isomer #3CNC(=O)C1=CC(OC2=CC=C(NC(=O)N(C3=CC=C(Cl)C(C(F)(F)F)=C3)[Si](C)(C)C(C)(C)C)C(F)=C2)=CC=N14414.5Standard polar33892256
Regorafenib,2TBDMS,isomer #1CN(C(=O)C1=CC(OC2=CC=C(N(C(=O)NC3=CC=C(Cl)C(C(F)(F)F)=C3)[Si](C)(C)C(C)(C)C)C(F)=C2)=CC=N1)[Si](C)(C)C(C)(C)C3839.5Semi standard non polar33892256
Regorafenib,2TBDMS,isomer #1CN(C(=O)C1=CC(OC2=CC=C(N(C(=O)NC3=CC=C(Cl)C(C(F)(F)F)=C3)[Si](C)(C)C(C)(C)C)C(F)=C2)=CC=N1)[Si](C)(C)C(C)(C)C3219.9Standard non polar33892256
Regorafenib,2TBDMS,isomer #1CN(C(=O)C1=CC(OC2=CC=C(N(C(=O)NC3=CC=C(Cl)C(C(F)(F)F)=C3)[Si](C)(C)C(C)(C)C)C(F)=C2)=CC=N1)[Si](C)(C)C(C)(C)C3946.4Standard polar33892256
Regorafenib,2TBDMS,isomer #2CN(C(=O)C1=CC(OC2=CC=C(NC(=O)N(C3=CC=C(Cl)C(C(F)(F)F)=C3)[Si](C)(C)C(C)(C)C)C(F)=C2)=CC=N1)[Si](C)(C)C(C)(C)C3821.9Semi standard non polar33892256
Regorafenib,2TBDMS,isomer #2CN(C(=O)C1=CC(OC2=CC=C(NC(=O)N(C3=CC=C(Cl)C(C(F)(F)F)=C3)[Si](C)(C)C(C)(C)C)C(F)=C2)=CC=N1)[Si](C)(C)C(C)(C)C3120.8Standard non polar33892256
Regorafenib,2TBDMS,isomer #2CN(C(=O)C1=CC(OC2=CC=C(NC(=O)N(C3=CC=C(Cl)C(C(F)(F)F)=C3)[Si](C)(C)C(C)(C)C)C(F)=C2)=CC=N1)[Si](C)(C)C(C)(C)C4010.1Standard polar33892256
Regorafenib,2TBDMS,isomer #3CNC(=O)C1=CC(OC2=CC=C(N(C(=O)N(C3=CC=C(Cl)C(C(F)(F)F)=C3)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C(F)=C2)=CC=N13650.7Semi standard non polar33892256
Regorafenib,2TBDMS,isomer #3CNC(=O)C1=CC(OC2=CC=C(N(C(=O)N(C3=CC=C(Cl)C(C(F)(F)F)=C3)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C(F)=C2)=CC=N13207.2Standard non polar33892256
Regorafenib,2TBDMS,isomer #3CNC(=O)C1=CC(OC2=CC=C(N(C(=O)N(C3=CC=C(Cl)C(C(F)(F)F)=C3)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C(F)=C2)=CC=N14117.1Standard polar33892256
Regorafenib,3TBDMS,isomer #1CN(C(=O)C1=CC(OC2=CC=C(N(C(=O)N(C3=CC=C(Cl)C(C(F)(F)F)=C3)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C(F)=C2)=CC=N1)[Si](C)(C)C(C)(C)C3908.8Semi standard non polar33892256
Regorafenib,3TBDMS,isomer #1CN(C(=O)C1=CC(OC2=CC=C(N(C(=O)N(C3=CC=C(Cl)C(C(F)(F)F)=C3)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C(F)=C2)=CC=N1)[Si](C)(C)C(C)(C)C3340.1Standard non polar33892256
Regorafenib,3TBDMS,isomer #1CN(C(=O)C1=CC(OC2=CC=C(N(C(=O)N(C3=CC=C(Cl)C(C(F)(F)F)=C3)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C(F)=C2)=CC=N1)[Si](C)(C)C(C)(C)C3799.8Standard polar33892256
Spectra

GC-MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Predicted GC-MSPredicted GC-MS Spectrum - Regorafenib GC-MS (Non-derivatized) - 70eV, Positivesplash10-0ha1-1972500000-861569d673c1973ffa362021-09-24Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Regorafenib GC-MS (Non-derivatized) - 70eV, PositiveNot Available2021-10-12Wishart LabView Spectrum

MS/MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Experimental LC-MS/MSLC-MS/MS Spectrum - Regorafenib , positive-QTOFsplash10-001i-0130900000-7cfbbe70d59d3990bb462017-09-14HMDB team, MONAView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Regorafenib 10V, Positive-QTOFsplash10-001i-0120900000-0a8e63a3e51536e785e72017-07-25Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Regorafenib 20V, Positive-QTOFsplash10-03la-0490300000-f4ddbfc325ad0b55a0402017-07-25Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Regorafenib 40V, Positive-QTOFsplash10-059j-2960000000-56c8b791198553f0e1012017-07-25Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Regorafenib 10V, Negative-QTOFsplash10-01qc-0560900000-6cb407647a185e4db3c62017-07-26Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Regorafenib 20V, Negative-QTOFsplash10-01ox-0790300000-9559a48445a46fb5f0bd2017-07-26Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Regorafenib 40V, Negative-QTOFsplash10-0006-4930000000-2ef929eaad8f315f3ff72017-07-26Wishart LabView Spectrum
Biological Properties
Cellular LocationsNot Available
Biospecimen Locations
  • Blood
Tissue LocationsNot Available
Pathways
Normal Concentrations
BiospecimenStatusValueAgeSexConditionReferenceDetails
BloodDetected but not QuantifiedNot QuantifiedNot SpecifiedNot SpecifiedNormal details
Abnormal Concentrations
Not Available
Associated Disorders and Diseases
Disease ReferencesNone
Associated OMIM IDsNone
DrugBank IDDB08896
Phenol Explorer Compound IDNot Available
FooDB IDNot Available
KNApSAcK IDNot Available
Chemspider ID9342697
KEGG Compound IDNot Available
BioCyc IDNot Available
BiGG IDNot Available
Wikipedia LinkRegorafenib
METLIN IDNot Available
PubChem CompoundNot Available
PDB IDNot Available
ChEBI ID68647
Food Biomarker OntologyNot Available
VMH IDNot Available
MarkerDB IDNot Available
Good Scents IDNot Available
References
Synthesis ReferenceNot Available
Material Safety Data Sheet (MSDS)Not Available
General References
  1. Barupal DK, Fiehn O: Generating the Blood Exposome Database Using a Comprehensive Text Mining and Database Fusion Approach. Environ Health Perspect. 2019 Sep;127(9):97008. doi: 10.1289/EHP4713. Epub 2019 Sep 26. [PubMed:31557052 ]